Compare PSTL & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PSTL | YDES |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 625.7M | 543.0M |
| IPO Year | 2018 | N/A |
| Metric | PSTL | YDES |
|---|---|---|
| Price | $24.00 | $2.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $20.19 | N/A |
| AVG Volume (30 Days) | ★ 316.0K | 312.1K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | ★ 4.62% | N/A |
| EPS Growth | ★ 123.81 | N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $95,823,000.00 | N/A |
| Revenue This Year | $18.01 | N/A |
| Revenue Next Year | $11.38 | N/A |
| P/E Ratio | $216.09 | ★ N/A |
| Revenue Growth | ★ 25.47 | N/A |
| 52 Week Low | $13.59 | $1.70 |
| 52 Week High | $25.22 | $25.00 |
| Indicator | PSTL | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 48.71 | 44.84 |
| Support Level | $23.71 | $2.14 |
| Resistance Level | $24.28 | $3.05 |
| Average True Range (ATR) | 0.53 | 0.32 |
| MACD | -0.10 | 0.07 |
| Stochastic Oscillator | 16.78 | 59.36 |
Postal Realty Trust Inc is an internally managed real estate investment trust. It is engaged in acquiring and managing properties mainly leased to the United States Postal Service, or the USPS, ranging from last-mile post offices to industrial facilities. The Trust's objective is to create stockholder value by generating risk-adjusted returns through expanding its portfolio of owned and managed postal properties leased to the USPS. The majority of its revenue is generated in the form of rental income.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.